Fundraising leverage Chrysalis manages one of Mid-America’s largest early-stage and growth funds with approximately $400 million under management, signaling substantial capital capacity and potential for follow-on funding opportunities with portfolio companies and Series A+ rounds.

Sector focus Targeted emphasis on Healthcare and Technology sectors undergoing significant transformation creates sales angles around digital health, health tech platforms, AI-enabled services, and disruptive healthcare delivery models.

Strategic value Chrysalis positions itself as a value-add partner providing business intelligence, market knowledge, and deep resources, suggesting opportunities to pitch comprehensive solutions that align with their disciplined investment approach.

Geographic footprint Headquartered in Louisville with an Mid-America emphasis, there is potential to prioritize regional deal flow, co-investment opportunities, and partnerships with local ecosystem players to accelerate portfolio company growth.

Portfolio activity Active investments across 65+ companies since 1993 and a history of funding rounds (evidenced by past bets like meQuilibrium) indicate receptiveness to scale-up solutions, talent platforms, and tools that support growth-stage ventures.